Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intersect ENT Inc (NASDAQ:XENT)

29.67
Delayed Data
As of Jul 31
 +0.15 / +0.51%
Today’s Change
12.11
Today|||52-Week Range
32.85
+59.95%
Year-to-Date
No recent news for Intersect ENT Inc.

Today’s Trading

Previous close29.52
Today’s open29.64
Day’s range29.12 - 30.13
Volume379,959
Average volume (3 months)383,365
Market cap$852.5M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-455.17%
Earnings growth (this year)+41.93%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+111.29%
P/E ratioNM
Price/Sales5.57
Price/Book13.35

Competitors

 Today’s
change
Today’s
% change
INGNInogen Inc+1.31+3.04%
KTWOK2M Group Holdings I...+0.43+1.92%
LMNXLuminex Corp+0.18+1.06%
CSIICardiovascular Syste...-0.06-0.20%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$37.9M
Annual profit (last year)-$18.4M
Net profit margin-48.47%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Lisa D. Earnhardt
COO, Senior VP-Research &
Development
Richard E. Kaufman
Corporate headquarters
Menlo Park, California

Forecasts